Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 2
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Oligoprogression After Immunotherapy and Targeted Therapy in Metastatic Melanoma.
Sobrevilla-Moreno N, Rivera-Sánchez D, García-Ortega D, López-Macías D, Garcilazo-Reyes A, Álvarez-Avitia M. Sobrevilla-Moreno N, et al. Among authors: lopez macias d. Oncology (Williston Park). 2021 Sep 16;35(9):562-566. doi: 10.46883/ONC.2021.3509.0562. Oncology (Williston Park). 2021. PMID: 34529396 No abstract available.
Nitroglycerin Plus Whole Intracranial Radiation Therapy for Brain Metastases in Patients With Non-Small Cell Lung Cancer: A Randomized, Open-Label, Phase 2 Clinical Trial.
Arrieta O, Hernández-Pedro N, Maldonado F, Ramos-Ramírez M, Yamamoto-Ramos M, López-Macías D, Lozano F, Zatarain-Barrón ZL, Turcott JG, Barrios-Bernal P, Orozco-Morales M, Flores-Estrada D, Cardona AF, Rolfo C, Cacho-Díaz B. Arrieta O, et al. Among authors: lopez macias d. Int J Radiat Oncol Biol Phys. 2023 Mar 1;115(3):592-607. doi: 10.1016/j.ijrobp.2022.02.010. Epub 2022 Feb 12. Int J Radiat Oncol Biol Phys. 2023. PMID: 35157994 Clinical Trial.
A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma.
Arrieta O, López-Macías D, Mendoza-García VO, Bacon-Fonseca L, Muñoz-Montaño W, Macedo-Pérez EO, Muñiz-Hernández S, Blake-Cerda M, Corona-Cruz JF. Arrieta O, et al. Among authors: lopez macias d. Cancer Chemother Pharmacol. 2014 May;73(5):975-82. doi: 10.1007/s00280-014-2429-5. Epub 2014 Apr 1. Cancer Chemother Pharmacol. 2014. PMID: 24687408 Clinical Trial.
Randomized, open-label trial evaluating the preventive effect of tetracycline on afatinib induced-skin toxicities in non-small cell lung cancer patients.
Arrieta O, Vega-González MT, López-Macías D, Martínez-Hernández JN, Bacon-Fonseca L, Macedo-Pérez EO, Ramírez-Tirado LA, Flores-Estrada D, de la Garza-Salazar J. Arrieta O, et al. Among authors: lopez macias d. Lung Cancer. 2015 Jun;88(3):282-8. doi: 10.1016/j.lungcan.2015.03.019. Epub 2015 Mar 28. Lung Cancer. 2015. PMID: 25882778 Clinical Trial.
Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non-Small Cell Lung Cancer.
Arrieta O, De la Torre-Vallejo M, López-Macías D, Orta D, Turcott J, Macedo-Pérez EO, Sánchez-Lara K, Ramírez-Tirado LA, Baracos VE. Arrieta O, et al. Among authors: lopez macias d. Oncologist. 2015 Aug;20(8):967-74. doi: 10.1634/theoncologist.2015-0058. Epub 2015 Jul 14. Oncologist. 2015. PMID: 26173839 Free PMC article. Clinical Trial.